MedTrace Logo

Oxygen Reserve Index in One-Lung Ventilation During Elective Thoracic Operations

NCT05050552 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-09-20

No results posted yet for this study

Summary

The investigators' goal is to perform an observational cohort study investigating the use of oxygen reserve index (ORi) in patients undergoing elective thoracic surgery and one-lung ventilation (OLV). For this purpose, ORi values are recorded and compared to the other collected hemodynamical and oximeter parameters. The primary hemodynamic parameters include heart rate (HR) and blood pressure (BP), while; oximeter device-related parameters include peripheral oxygen saturation, perfusion index (PI), and pleth variability index (PVI).

The investigators' secondary goal is to investigate relationships between these hemodynamical and oximeter parameters using statistical analysis methods.

Conditions

  • One-Lung Ventilation
  • Hypoxemia During Surgery
  • Oxygen Reserve Index
  • Perfusion Index
  • Pleth Variability Index

Interventions

DEVICE

Masimo Radical-7 Pulse CO-Oximeter

The Masimo Radical-7 Pulse CO-Oximeter is a device for the measurement of pulse oximetry, oxygen reserve index (ORi), perfusion index (PI), and pleth variability index (PVI). The device is the product of a company called Masimo Inc, Irvine, CA, USA

Sponsors & Collaborators

  • Trakya University

    lead OTHER

Principal Investigators

  • Hasan Umit, MD · Trakya University, Trakya University Training and Research Hospital, Edirne, Turkey, 22030

Eligibility

Min Age
22 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2021-07-15
Completion
2021-08-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05050552 on ClinicalTrials.gov